Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC
Author(s) -
Edgardo Pezzetta,
Roger Stupp,
A. Zouhair,
L GUILLOU,
Patrick Taffé,
C VONBRIEL,
Tess M. Krueger,
H. Ris
Publication year - 2005
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2005.02.035
Subject(s) - medicine , cisplatin , mediastinoscopy , chemotherapy , neoadjuvant therapy , stage (stratigraphy) , mediastinal lymph node , pneumonectomy , lymph node , lung cancer , surgery , induction chemotherapy , radiology , oncology , cancer , metastasis , paleontology , breast cancer , biology
Comparison of prospectively treated patients with neoadjuvant cisplatin-based chemotherapy vs radiochemotherapy followed by resection for mediastinoscopically proven stage III N2 non-small cell lung cancer with respect to postoperative morbidity, pathological nodal downstaging, overall and disease-free survival, and site of recurrence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom